Reply: CD133 expression in different stages of gastric adenocarcinoma

por Smith, L M, Nesterova, A, Ryan, M C, Duniho, S, Jonas, M, Anderson, M, Sutherland, M K, Van Orden, K L, Moore, P A, Ruben, S M, Carter, P J
Publicado 2009

A phase II trial of lomeguatrib and temozolomide in metastatic colorectal cancer

por Khan, O A, Ranson, M, Michael, M, Olver, I, Levitt, N C, Mortimer, P, Watson, A J, Margison, G P, Midgley, R, Middleton, M R
Publicado 2009

Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis

por Rasheed, S, Harris, A L, Tekkis, P P, Turley, H, Silver, A, McDonald, P J, Talbot, I C, Glynne-Jones, R, Northover, J M A, Guenther, T
Publicado 2009

Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis

por Leung, G M, Thach, T Q, Lam, T-H, Hedley, A J, Foo, W, Fielding, R, Yip, P S F, Lau, E M C, Wong, C-M
Publicado 2003

Tamoxifen: the drug that came in from the cold

por Hughes-Davies, L, Caldas, C, Wishart, G C
Publicado 2009

Granisetron vs ondansetron: is it a question of duration of 5-HT(3) receptor blockade?

por Blower, P, Aapro, M
Publicado 2002

Neuroblastoma in monozygotic twins – a case of probable twin to twin metastasis

por Anderson, J, Kempski, H, Hill, L, Rampling, D, Gordon, T, Michalski, A
Publicado 2002

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study

por Bjørge, T, Engeland, A, Luostarinen, T, Mork, J, Gislefoss, R E, Jellum, E, Koskela, P, Lehtinen, M, Pukkala, E, Thoresen, S Ø, Dillner, J
Publicado 2004

Chemotherapy for early-stage breast cancer: a brief history

por Verrill, M
Publicado 2009

Summary report of the Standards, Options and Recommendations for the use of serum tumour markers in breast cancer: 2000

por Basuyau, J P, Blanc-Vincent, M P, Bidart, J M, Daver, A, Deneux, L, Eche, N, Gory-Delabaere, G, Pichon, M F, Riedinger, J M
Publicado 2003

Standards, Options and Recommendations for the use of appetite stimulants in oncology (2000)

por Desport, J C, Gory-Delabaere, G, Blanc-Vincent, M P, Bachmann, P, Béal, J, Benamouzig, R, Colomb, V, Kere, D, Melchior, J C, Nitenberg, G, Raynard, B, Schneider, S, Senesse, P
Publicado 2003

Summary version of the Standards, Options and Recommendations for palliative or terminal nutrition in adults with progressive cancer (2001)

por Bachmann, P, Marti-Massoud, C, Blanc-Vincent, M P, Desport, J C, Colomb, V, Dieu, L, Kere, D, Melchior, J C, Nitenberg, G, Raynard, B, Roux-Bournay, P, Schneider, S, Senesse, P
Publicado 2003

Summary of the Standards, Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)

por Bugat, R, Bataillard, A, Lesimple, T, Voigt, J J, Culine, S, Lortholary, A, Merrouche, Y, Ganem, G, Kaminsky, M C, Negrier, S, Perol, M, Laforêt, C, Bedossa, P, Bertrand, G, Coindre, J M, Fizazi, K
Publicado 2003

Summary of the Standards, Options and Recommendations for nutritional support in patients undergoing bone marrow transplantation (2002)

por Raynard, B, Nitenberg, G, Gory-Delabaere, G, Bourhis, J H, Bachmann, P, Bensadoun, R J, Desport, J C, Kere, D, Schneider, S, Senesse, P, Bordigoni, P, Dieu, L
Publicado 2003

Reply: Somatic mutations are present in all members of the AKT family in endometrial carcinoma

por Shoji, K, Oda, K, Nakagawa, S, Hosokawa, S, Nagae, G, Uehara, Y, Sone, K, Miyamoto, Y, Hiraike, H, Hiraike-Wada, O, Nei, T, Kawana, K, Kuramoto, H, Aburatani, H, Yano, T, Taketani, Y
Publicado 2009

Glasgow Prognostic Score as a predictive factor differentiating surgical site infection and remote infection following colorectal cancer surgery?

por Miki, C, Mohri, Y, Toiyama, Y, Araki, T, Tanaka, K, Inoue, Y, Uchida, K, Kusunoki, M
Publicado 2009

Mechanisms of HTLV-1 persistence and transformation

por Boxus, M, Willems, L
Publicado 2009

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways

por Cleton-Jansen, A-M, Anninga, J K, Briaire-de Bruijn, I H, Romeo, S, Oosting, J, Egeler, R M, Gelderblom, H, Taminiau, A H M, Hogendoorn, P C W
Publicado 2009

Reply: SUN vs BEVþIFN in first-line mRCC therapy: no evidence for a statistically significant difference in progression-free survival

por Thompson Coon, J S, Liu, Z, Hoyle, M, Rogers, G, Green, C, Moxham, T, Welch, K, Stein, K
Publicado 2010

Cellular senescence induced by aberrant MAD2 levels impacts on paclitaxel responsiveness in vitro

por Prencipe, M, Fitzpatrick, P, Gorman, S, Tosetto, M, Klinger, R, Furlong, F, Harrison, M, O'Connor, D, Roninson, I B, O'Sullivan, J, McCann, A
Publicado 2010